Sarepta Therapeutics(SRPT) - 2025 Q3 - Earnings Call Presentation

November 3, 2025 Q3 2025 Earnings Conference Call Patients can't wait for the next breakthrough in medical research. So neither will we. Doug Ingram CEO Louise Rodino-Klapac, PhD President, R&D and Technical Operations Patrick E. Moss, PharmD Executive Vice President, Chief Commercial Officer Ryan H. Wong Executive Vice President, Chief Financial Officer DILLON Living with Duchenne muscular dystrophy ©SAREPTA THERAPEUTICS, INC. 2025. ALL RIGHTS RESERVED. 1 Forward-looking statements In order to provide Sare ...